Title Dysregulation of KSHV Replication by Extracts from Carthamus tinctorius L.
Author Han Lee1, Hyosun Cho2, Myoungki Son1, Gi-Ho Sung3, Taeho Lee4, Sang-Won Lee5, Yong Woo Jung6, Yu Su Shin5, and Hyojeung Kang1
Address 1College of Pharmacy and Research Institute of Pharmaceutical Sciences, Institute for Microorganisms, Kyungpook National University, Daegu 702-701, Republic of Korea, 2College of Pharmacy, Duksung Women’s University, Seoul 132-714, Republic of Korea, 3Mushroom Research Division, National Institute of Horticultural and Herbal Science, Rural Development Administration, Suwon 440-706, Republic of Korea, 4Research Center, Dong-a Pharm. Co., LTD., Yongin 446-905, Republic of Korea, 5Department of Medicinal Crop Research, National Institute of Horticultural and Herbal Science, Rural Development Administration, Eumseong 369-873, Republic of Korea, 6College of Pharmacy, Korea University, Sejong 339-700, Republic of Korea
Bibliography Journal of Microbiology, 51(4),490-498, 2013,
DOI 10.1007/s12275-013-3282-7
Key Words Carthamus tinctorius L., Kaposi’s sarcoma-associated herpesvirus, extracts, latency, lytic reactivation
Abstract Carthamus tinctorius L. (CT) is traditionally used to reduce ailments from diseases of the musculoskeletal system and connective tissue and diseases of blood circulation and the cardiovascular system. Flower extracts from CT are known to have antibacterial activity, anti-inflammatory activity, and to inhibit tumor promotion in mouse skin carcinogenesis. In order to discover new antiviral agents from CT extracts, we tested whether CT extracts contain antiviral activity against gammaherpesvirus infection. This study demonstrated that treatment with CT extracts disrupted KSHV latency in the viral-infected host cells, iSLK-BAC16. n-Hexane and EtOH fractions of CT extracts critically affected at least two stages of the KHSV life-cycle by abnormally inducing KSHV lytic reactivation and by severely preventing KSHV virion release from the viral host cells. In addition to the effects on KSHV itself, CT extract treatments induced cellular modifications by dysregulating cell-cycle and producing strong cytotoxicity. This study demonstrated for the first time that CT extracts have antiviral activities that could be applied to development of new anti-gammaherpesviral agents.